For more than 60 years the Cancer and Blood Disease Institute at Children’s Hospital Los Angeles has been committed to increasing cure rates and improving quality of survival for children, adolescents and young adults through outstanding clinical care, innovative research, academic excellence and global leadership.

The Cancer and Blood Disease Institute has been ranked among the leading pediatric cancer programs in the United States by U.S. News & World Report every year since the rankings were launched in 2008.

Adam Wernow, a longtime distance runner, doesn’t consider patience one of his virtues, but tenacity sure is. It was this trait that led the Long Island, New York, man to Hackensack Meridian Health after he refused to resign himself to a sedentary life when he experienced symptoms that made running impossible.

Children’s National Hospital will leverage low-intensity focused ultrasound (LIFU) to deliver therapy directly to a child’s high-grade glioma. The approach offers doctors the first opportunity to open the blood-brain barrier and treat the entire malignant brain tumor.

Provider CornerFEATURING:August 4, 2022Memorial Regional Hospital South Introduces Next-Generation Robotic Technology for Digital Precision in Knee ReplacementWith 900,000 knee replacements being performed in the United States each year, patients and surgeons alike are seeking the latest technology as they aim for improved outcomes, including greater mobility, less discomfort and a more rapid recovery. The award-winning surgeons at Memorial Orthopaedic Surgery and Sports …

ROCHESTER, Minn. — Jim Nemecek was feeling fine last autumn. He had healed well from a 2020 spine surgery at Mayo Clinic called a diskectomy, and the active 69-year-old from the Atlanta area was doing what he loves best: playing tennis.

After serving the ball, he felt a familiar sensation. He had ruptured a disk in his back again. Jim called his surgeon to let him know what happened.

Provider CornerFEATURING:July 7, 2022Fluorescent Imaging Technology Available at Moffitt Cancer Center for Ovarian Cancer SurgeryCytalux™, an FDA-approved optical imaging agent, is now available at Moffitt Cancer Center. This treatment is for adult patients with ovarian cancer and can be used as an adjunct for the intraoperative identification of malignant lesions. Moffitt is the first institution in the country that was part of Phase …

Provider CornerFEATURING: June 30, 2022The Heart Institute at Children’s Hospital Los Angeles: Delivering World-Class Pediatric Cardiac CareThe Heart Institute at Children’s Hospital Los Angeles is a preeminent referral center for diseases of the heart and circulation in childhood, attracting families from across the United States and around the world. Each component of care has been designed with children and families …

Provider CornerFEATURING: June 9, 2022Penn Researchers Shorten Manufacturing Time for CAR T Cell TherapyA new approach allowed scientists to alter immune cells within 24 hours versus the standard of up to two weeks PHILADELPHIA— A new approach from Penn Medicine researchers could cut the time it takes to alter patients’ immune cells for infusion back into the body to find and attack …